RARE - Ultragenyx Pharmaceutical Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts15151718
Avg. Estimate-1.72-1.69-6.91-4.9
Low Estimate-1.89-1.92-7.31-6.66
High Estimate-1.62-1.52-6.46-1.97
Year Ago EPS-1.06-1.74-3.97-6.91
Revenue EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts13131617
Avg. Estimate22.15M26.51M97.29M210.98M
Low Estimate19.63M22.02M85.9M142.1M
High Estimate26.36M31.7M108.6M311.64M
Year Ago Sales12.79M11.76M51.49M97.29M
Sales Growth (year/est)73.10%125.40%88.90%116.90%
Earnings History6/29/20189/29/201812/30/20183/30/2019
EPS Est.-2.09-1.96-1.79-1.74
EPS Actual-1.06-1.74-1.73-1.82
Difference1.030.220.06-0.08
Surprise %49.30%11.20%3.40%-4.60%
EPS TrendCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Current Estimate-1.72-1.69-6.91-4.9
7 Days Ago-1.72-1.69-6.91-4.9
30 Days Ago-1.72-1.69-6.91-4.9
60 Days Ago-1.68-1.63-6.48-4.51
90 Days Ago-1.7-1.62-6.58-4.52
EPS RevisionsCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesRAREIndustrySectorS&P 500
Current Qtr.-62.30%N/AN/A0.02
Next Qtr.2.90%N/AN/A0.04
Current Year-74.10%N/AN/A0.05
Next Year29.10%N/AN/A0.10
Next 5 Years (per annum)17.20%N/AN/A0.10
Past 5 Years (per annum)N/AN/AN/AN/A